End Treatment Response and Sustained Viral Response in Patients With Hepatitis C Virus Receiving Sofosbuvir and Daclatasvir

Objective The main purpose of this study was to determine the end treatment response (ETR) and sustained viral response (SVR) in hepatitis C virus (HCV) patients receiving sofosbuvir and daclatasvir daily for 12 weeks. Methods This is a prospective open-label interventional study conducted from Marc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Attiya S, Amir, Muhammad, Jamal, Qaiser, Riaz, Mehwish, Fareed, Komal, Siddiqui, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253241/
https://www.ncbi.nlm.nih.gov/pubmed/37303399
http://dx.doi.org/10.7759/cureus.38833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253241/
https://www.ncbi.nlm.nih.gov/pubmed/37303399
http://dx.doi.org/10.7759/cureus.38833

Ejemplares similares